The company's financial foundation appears increasingly vulnerable, with the debt-to-equity ratio surging to 1.77 in 2026Q1 compared to 0.70 in 2023Q4.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 1.84B | 2.02B | 1.75B | 1.97B | 1.89B | 1.85B | 1.8B | 2B | 1.89B | 2B | 1.88B | 1.2B | 1.21B | 1.14B | 1.11B | 1.01B | 1.32B | 1.22B | 949.86M | 982.02M | 718.19M | 1.03B | 1.06B | 727.45M | 541M | 484.24M | 325.45M | 314.7M | 322.5M | 277M | 256.7M |
| Cash & Short-Term Investments | 190M | 326M | 272M | 334M | 365M | 339M | 438M | 405M | 309.6M | 320.6M | 383.9M | 284.6M | 151.64M | 74.95M | 80.13M | 77.13M | 540.04M | 450.38M | 204.25M | 316.32M | 65.14M | 434.52M | 506.37M | 163.75M | 25.65M | 33.71M | 15.43M | 7.3M | 8.7M | 9.8M | 5.6M |
| Cash Only | 190M | 326M | 272M | 334M | 365M | 339M | 438M | 405M | 309.6M | 320.6M | 383.9M | 284.6M | 151.64M | 74.95M | 80.13M | 77.13M | 540.04M | 450.35M | 203.99M | 169.38M | 65.06M | 434.52M | 506.37M | 163.75M | 25.65M | 33.71M | 15.43M | 7.3M | 8.7M | 9.8M | 5.6M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37K | 258K | 146.94M | 79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 622M | 688M | 606M | 756M | 685M | 803M | 706M | 828M | 701.9M | 746.2M | 636M | 399.9M | 426.6M | 472.8M | 442.41M | 427.71M | 344.8M | 348.68M | 319.26M | 307.62M | 290.79M | 254.82M | 238.87M | 241.38M | 221.26M | 191.53M | 133.64M | 127.91M | 134.2M | 114.4M | 102M |
| Days Sales Outstanding | 64.7 | 68.24 | 58.32 | 69.59 | 63.75 | 69.27 | 77.18 | 75.14 | 64.27 | 68.2 | 61.98 | 54.58 | 53.28 | 58.48 | 55.14 | 61.52 | 56.66 | 58.92 | 53.12 | 55.87 | 58.62 | 54.23 | 51.46 | 56.09 | 53.35 | 61.92 | 54.82 | 56.19 | 61.61 | 57.93 | 56.7 |
| Inventory | 659M | 642M | 564M | 624M | 627M | 515M | 476M | 562M | 598.9M | 623.1M | 517.1M | 340.4M | 387.1M | 438.56M | 402.94M | 361.76M | 308.74M | 291.64M | 306.13M | 258.03M | 232.44M | 208.18M | 213.71M | 205.59M | 214.49M | 197.45M | 133.3M | 135.5M | 139.2M | 124.7M | 125.4M |
| Days Inventory Outstanding | 129.21 | 127.35 | 112.19 | 121.21 | 127.5 | 99.77 | 103.23 | 110.4 | 113.94 | 126.01 | 108.2 | 107.38 | 106.81 | 116.56 | 107.19 | 104.44 | 103.3 | 101.51 | 107.25 | 97.19 | 96.25 | 89.8 | 92.02 | 94.07 | 100.26 | 128.83 | 126.43 | 137.65 | 148.91 | 142.41 | 150.66 |
| Other Current Assets | 374M | 367M | 153M | 146M | 88M | 84M | 67M | 84M | 172.8M | 120.7M | 122.9M | 132.9M | 150.08M | 121.36M | 130.73M | 113.41M | 0 | -37K | 0 | 0 | 0 | -3.04M | 0 | 28.26M | 0 | 61.55M | 43.07M | 44M | 40.4M | 28.1M | 23.7M |
| Total Non-Current Assets | 3.38B | 3.41B | 4.01B | 5.4B | 5.75B | 7.39B | 7.55B | 6.6B | 6.8B | 8.38B | 9.77B | 3.21B | 3.44B | 3.93B | 3.86B | 3.74B | 1.94B | 1.87B | 1.88B | 1.69B | 1.46B | 1.38B | 1.74B | 1.72B | 1.55B | 1.31B | 541.16M | 544.9M | 572.8M | 497.4M | 411M |
| Property, Plant & Equipment | 997M | 1B | 902M | 978M | 961M | 971M | 967M | 961M | 870.6M | 876M | 799.8M | 558.8M | 588.85M | 637.17M | 614.71M | 591.45M | 423.11M | 439.62M | 432.28M | 371.41M | 329.62M | 316.22M | 407.53M | 376.21M | 313.18M | 240.89M | 181.34M | 180.5M | 159M | 147.1M | 141.5M |
| Fixed Asset Turnover | 3.73x | 3.68x | 4.21x | 4.05x | 4.08x | 4.36x | 3.45x | 4.19x | 4.58x | 4.56x | 4.68x | 4.79x | 4.96x | 4.63x | 4.76x | 4.29x | 5.25x | 4.91x | 5.07x | 5.41x | 5.49x | 5.42x | 4.16x | 4.18x | 4.83x | 4.69x | 4.91x | 4.60x | 5.00x | 4.90x | 4.64x |
| Goodwill | 1.14B | 1.15B | 1.6B | 2.44B | 2.69B | 3.98B | 3.99B | 3.4B | 3.43B | 4.52B | 5.95B | 1.99B | 2.09B | 2.28B | 2.21B | 2.19B | 1.3B | 1.31B | 1.28B | 1.13B | 995.38M | 0 | 0 | 0 | 0 | 763.27M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 924M | 974M | 1.21B | 1.71B | 1.9B | 2.32B | 2.5B | 2.18B | 2.42B | 2.83B | 2.96B | 600.7M | 670.84M | 795.32M | 830.64M | 791.1M | 78.74M | 89.09M | 103.72M | 76.17M | 67.65M | 1B | 1.25B | 1.21B | 1.13B | 248.89M | 344.75M | 349.4M | 346.1M | 103.5M | 256.2M |
| Long-Term Investments | 0 | 0 | 23M | 0 | 0 | 0 | 0 | 0 | -552.8M | -718M | -848.6M | -160.3M | -165.55M | -238.39M | -232.64M | -249.82M | -72.49M | -72.52M | -69.05M | -60.55M | -53.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 321M | 284M | 278M | 48M | 198M | 121M | 95M | 69M | 76.8M | 156.2M | 64.1M | 59.1M | 94.27M | 220.15M | 204.9M | 169.89M | 138M | 28.84M | 67.52M | 118.55M | 70.51M | 59.24M | 79.86M | 132.19M | 98.35M | 60.86M | 15.07M | 15M | 67.7M | 246.8M | 13.3M |
| Total Assets | 5.23B | 5.43B | 5.75B | 7.37B | 7.64B | 9.24B | 9.35B | 8.6B | 8.69B | 10.38B | 11.66B | 4.4B | 4.65B | 5.08B | 4.97B | 4.76B | 3.26B | 3.09B | 2.83B | 2.68B | 2.18B | 2.41B | 2.8B | 2.45B | 2.09B | 1.8B | 866.62M | 859.6M | 895.3M | 774.4M | 667.7M |
| Asset Turnover | 0.66x | 0.68x | 0.66x | 0.54x | 0.51x | 0.46x | 0.36x | 0.47x | 0.46x | 0.38x | 0.32x | 0.61x | 0.63x | 0.58x | 0.59x | 0.53x | 0.68x | 0.70x | 0.78x | 0.75x | 0.83x | 0.71x | 0.61x | 0.64x | 0.73x | 0.63x | 1.03x | 0.97x | 0.89x | 0.93x | 0.98x |
| Asset Growth % | -45.89% | -5.63% | -21.94% | -3.57% | -17.27% | -1.19% | 8.68% | -0.97% | -16.31% | -10.95% | 164.74% | -5.32% | -8.42% | 2.13% | 4.56% | 45.96% | 5.51% | 9.1% | 5.79% | 22.66% | -9.39% | -13.97% | 14.42% | 17.18% | 16.07% | 107.49% | 0.82% | -3.99% | 15.61% | 15.98% | 11.71% |
| Total Current Liabilities | 1.21B | 1.34B | 1.59B | 1.43B | 1.17B | 1.26B | 1.37B | 995M | 1.01B | 946.6M | 771M | 476M | 653.59M | 796.4M | 927.78M | 724.07M | 360.09M | 444.56M | 359.96M | 312.41M | 311.43M | 741.23M | 404.61M | 337.68M | 365.75M | 358.52M | 168.14M | 176.2M | 194.4M | 169.3M | 143.2M |
| Accounts Payable | 259M | 300M | 241M | 305M | 279M | 262M | 302M | 308M | 283.9M | 284.4M | 223M | 133.6M | 132.6M | 132.79M | 165.29M | 149.12M | 114.48M | 100.85M | 104.33M | 82.32M | 79.95M | 82.32M | 91.58M | 86.34M | 66.63M | 69.9M | 45.76M | 44.61M | 42.7M | 38.9M | 33.7M |
| Days Payables Outstanding | 53.15 | 59.51 | 47.94 | 59.25 | 56.73 | 50.76 | 65.5 | 60.51 | 54.01 | 57.51 | 46.66 | 42.14 | 36.59 | 35.29 | 43.97 | 43.05 | 38.3 | 35.1 | 36.55 | 31.01 | 33.11 | 35.51 | 39.43 | 39.5 | 31.14 | 45.61 | 43.4 | 45.32 | 45.68 | 44.43 | 40.49 |
| Short-Term Debt | 230M | 360M | 549M | 322M | 118M | 182M | 299M | 2M | 92.4M | 30.1M | 21.1M | 12.1M | 112.83M | 309.86M | 298.96M | 276.7M | 7.75M | 82.17M | 25.8M | 1.24M | 3M | 412.21M | 72.88M | 21.97M | 4.55M | 7.63M | 794K | 20.2M | 16.3M | 24M | 26.7M |
| Deferred Revenue (Current) | 271M | 74M | 95M | 91M | 84M | 68M | 53M | 29M | 29.3M | 8.9M | 14.1M | 2.2M | 3.48M | 4.92M | 5.51M | 0 | 0 | -110.5M | 0 | 189.41M | 181.2M | 159.85M | 179.76M | 172.68M | 190.78M | 194.36M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 718M | 408M | 64M | 458M | 182M | 212M | 166M | 128M | 339.1M | 353.3M | 260.1M | 166.9M | 8.28M | 197.58M | 287.6M | 163.48M | 146.32M | 0 | 108.29M | 0 | 114.86M | 105.55M | 122.03M | 56.69M | 103.79M | 86.62M | 121.58M | 111.39M | 135.4M | 106.4M | 82.8M |
| Current Ratio | 1.53x | 1.51x | 1.10x | 1.38x | 1.62x | 1.47x | 1.31x | 2.01x | 1.86x | 2.12x | 2.44x | 2.51x | 1.85x | 1.44x | 1.20x | 1.40x | 3.65x | 2.74x | 2.64x | 3.14x | 2.31x | 1.39x | 2.61x | 2.15x | 1.48x | 1.35x | 1.94x | 1.79x | 1.66x | 1.64x | 1.79x |
| Quick Ratio | 0.98x | 1.03x | 0.74x | 0.95x | 1.08x | 1.06x | 0.96x | 1.45x | 1.27x | 1.46x | 1.77x | 1.80x | 1.25x | 0.89x | 0.76x | 0.90x | 2.79x | 2.08x | 1.79x | 2.32x | 1.56x | 1.11x | 2.08x | 1.55x | 0.89x | 0.80x | 1.14x | 1.02x | 0.94x | 0.90x | 0.92x |
| Cash Conversion Cycle | 140.76 | 136.08 | 122.56 | 131.56 | 134.51 | 118.29 | 114.91 | 125.04 | 124.2 | 136.7 | 123.52 | 119.81 | 123.5 | 139.75 | 118.36 | 122.91 | 121.66 | 125.33 | 123.82 | 122.05 | 121.77 | 108.52 | 104.05 | 110.65 | 122.47 | 145.14 | 137.85 | 148.52 | 164.84 | 155.92 | 166.87 |
| Total Non-Current Liabilities | 2.7B | 2.75B | 2.22B | 2.65B | 2.66B | 2.98B | 3.04B | 2.51B | 2.54B | 2.79B | 2.76B | 1.59B | 1.67B | 1.7B | 1.8B | 2.15B | 987.95M | 736.42M | 882.72M | 846.76M | 595.86M | 424.33M | 948.97M | 985.42M | 884.1M | 829.68M | 173.55M | 212M | 284.4M | 177.2M | 154.6M |
| Long-Term Debt | 2.1B | 2.02B | 1.59B | 1.8B | 1.83B | 1.91B | 1.98B | 1.43B | 1.56B | 1.61B | 1.51B | 1.14B | 1.15B | 1.17B | 1.22B | 1.49B | 604.01M | 387.15M | 423.68M | 482.06M | 367.16M | 270.1M | 779.94M | 790.2M | 769.82M | 723.52M | 109.5M | 145.3M | 217.5M | 105.5M | 75.1M |
| Capital Lease Obligations | 270M | 93M | 91M | 125M | 149M | 149M | 130M | 120M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 374M | 86M | 129M | 0 | 287M | 391M | 381M | 480M | 552.8M | 718M | 848.6M | 160.3M | 165.55M | 238.39M | 232.64M | 249.82M | 72.49M | 72.52M | 69.05M | 60.55M | 53.19M | 42.91M | 58.2M | 51.24M | 27.04M | 32.53M | 16.82M | 20.2M | 18.8M | 27.6M | 30M |
| Other Non-Current Liabilities | 518M | 457M | 415M | 730M | 399M | 528M | 554M | 480M | 975.8M | 1.18B | 1.25B | 446.5M | 521.59M | 537.49M | 573.04M | 657.16M | 383.93M | 349.27M | 389.99M | 364.69M | 175.51M | 111.31M | 110.83M | 143.97M | 87.24M | 73.63M | 47.23M | 46.5M | 48.1M | 44.1M | 49.5M |
| Total Liabilities | 3.91B | 4.09B | 3.81B | 4.08B | 3.83B | 4.24B | 4.42B | 3.51B | 3.55B | 3.74B | 3.53B | 2.06B | 2.33B | 2.5B | 2.72B | 2.87B | 1.35B | 1.18B | 1.24B | 1.16B | 907.29M | 1.17B | 1.35B | 1.32B | 1.25B | 1.19B | 341.68M | 388.2M | 478.8M | 346.5M | 297.8M |
| Total Debt | 2.33B | 2.47B | 2.27B | 2.3B | 2.15B | 2.29B | 2.46B | 1.6B | 1.66B | 1.61B | 1.51B | 1.14B | 1.15B | 1.17B | 1.22B | 1.49B | 604.01M | 387.15M | 449.47M | 483.31M | 370.16M | 682.32M | 852.82M | 812.17M | 774.37M | 731.16M | 110.29M | 165.5M | 233.8M | 129.5M | 101.8M |
| Net Debt | 2.14B | 2.14B | 2B | 1.97B | 1.78B | 1.96B | 2.02B | 1.19B | 1.35B | 1.29B | 1.13B | 856.4M | 1B | 1.09B | 1.14B | 1.41B | 63.98M | -63.2M | 245.48M | 313.92M | 305.09M | 247.79M | 346.45M | 648.42M | 748.72M | 697.45M | 94.86M | 158.2M | 225.1M | 119.7M | 96.2M |
| Debt / Equity | 1.77x | 1.84x | 1.17x | 0.70x | 0.56x | 0.46x | 0.50x | 0.31x | 0.32x | 0.24x | 0.19x | 0.49x | 0.50x | 0.45x | 0.54x | 0.79x | 0.32x | 0.20x | 0.28x | 0.32x | 0.29x | 0.55x | 0.59x | 0.72x | 0.92x | 1.20x | 0.21x | 0.35x | 0.56x | 0.30x | 0.28x |
| Debt / EBITDA | 5.50x | 4.09x | - | 8.91x | - | 2.40x | 7.42x | 2.37x | - | - | 2.08x | 2.29x | 2.01x | 2.13x | 2.39x | 3.86x | 1.35x | 0.87x | 1.03x | 1.19x | 1.02x | 5.53x | 2.48x | 2.59x | 2.58x | 3.14x | 0.54x | 0.87x | 1.31x | 0.79x | 0.69x |
| Net Debt / EBITDA | 5.05x | 3.55x | - | 7.62x | - | 2.05x | 6.09x | 1.77x | - | - | 1.55x | 1.72x | 1.74x | 1.99x | 2.23x | 3.66x | 0.14x | -0.14x | 0.56x | 0.77x | 0.84x | 2.01x | 1.01x | 2.07x | 2.49x | 3.00x | 0.46x | 0.84x | 1.26x | 0.73x | 0.65x |
| Interest Coverage | -5.12x | -4.52x | -12.57x | -1.16x | -15.23x | 9.93x | -0.06x | 12.41x | -24.69x | -40.93x | 13.28x | 6.90x | 9.51x | 8.40x | 6.82x | 6.72x | 14.89x | 21.61x | 11.93x | 31.88x | 30.19x | 17.20x | 12.04x | 10.42x | 6.65x | - | 16.14x | 17.60x | 0.90x | 16.36x | 19.92x |
| Total Equity | 1.32B | 1.34B | 1.94B | 3.29B | 3.81B | 5B | 4.93B | 5.09B | 5.13B | 6.64B | 8.13B | 2.34B | 2.32B | 2.58B | 2.25B | 1.88B | 1.91B | 1.91B | 1.59B | 1.52B | 1.27B | 1.24B | 1.44B | 1.12B | 837.19M | 609.96M | 524.93M | 471.4M | 416.5M | 427.9M | 369.9M |
| Equity Growth % | -142.05% | -31.03% | -41.01% | -13.59% | -23.71% | 1.26% | -3.14% | -0.74% | -22.71% | -18.27% | 247.35% | 0.74% | -9.92% | 14.61% | 19.39% | -1.35% | 0.15% | 20.11% | 4.7% | 19.02% | 2.6% | -14.04% | 28.69% | 34.08% | 37.25% | 16.2% | 11.36% | 13.18% | -2.66% | 15.68% | 15.85% |
| Book Value per Share | 6.60 | 6.72 | 9.56 | 15.54 | 17.69 | 22.69 | 22.51 | 22.70 | 22.88 | 28.95 | 36.67 | 16.42 | 16.10 | 17.78 | 15.63 | 13.13 | 13.08 | 12.70 | 10.47 | 9.80 | 8.05 | 7.66 | 8.81 | 6.96 | 5.23 | 3.86 | 3.34 | 2.97 | 2.59 | 2.63 | 2.29 |
| Total Shareholders' Equity | 1.32B | 1.34B | 1.94B | 3.29B | 3.81B | 5B | 4.93B | 5.09B | 5.12B | 6.63B | 8.11B | 2.34B | 2.32B | 2.54B | 2.21B | 1.85B | 1.84B | 1.83B | 1.59B | 1.52B | 1.27B | 1.24B | 1.44B | 1.12B | 835.93M | 609.52M | 520.37M | 468.9M | 413.8M | 423.9M | 365.6M |
| Common Stock | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 2.6M | 2.6M | 2.6M | 1.6M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 1.63M | 814K | 814K | 814K | 814K | 814K | 814K | 543K | 500K | 0 | 0 | 0 |
| Retained Earnings | -1.57B | -1.56B | -835M | 205M | 456M | 1.51B | 1.2B | 1.4B | 1.23B | 2.32B | 3.95B | 3.59B | 3.38B | 3.1B | 2.82B | 2.54B | 2.32B | 2.08B | 1.84B | 1.58B | 1.35B | 1.15B | 1.13B | 889.6M | 730.97M | 597.41M | 490.17M | 402.4M | 324.7M | 301.1M | 237.3M |
| Treasury Stock | 0 | -3.1B | -3.14B | -2.92B | -2.65B | -2.54B | -2.41B | -2.3B | -2.15B | -1.96B | -1.65B | -898.4M | -841.6M | -748.51M | -713.74M | -727.98M | -711.65M | -532.02M | -479.63M | -387.11M | -328.18M | -138.15M | -36.48M | -39.84M | -52.48M | -60.82M | -68M | -35.92M | 0 | 0 | 0 |
| Accumulated OCI | -655M | -639M | -730M | -636M | -628M | -592M | -464M | -600M | -478.7M | -291M | -705.7M | -594M | -441.14M | -69.06M | -144.2M | -190.97M | 24.16M | 83.54M | 39.61M | 145.82M | 79.91M | 56.45M | 164.1M | 104.54M | -275K | -80.81M | -54.23M | -49.7M | -80.2M | -65M | -56.3M |
| Minority Interest | 0 | 1M | 1M | 1M | 1M | 1M | 3M | 2M | 11.9M | 11.6M | 11.6M | 1.4M | 919K | 42.92M | 40.74M | 36.07M | 70.53M | 74.85M | 0 | 296K | 222K | 188K | 600K | 418K | 1.26M | 437K | 4.56M | 2.5M | 2.7M | 4M | 4.3M |
Rapidly Deteriorating Equity Base
According to recent quarterly filings, XRAY's total equity has plummeted from $3.3 billion in 2023Q4 to $1.3 billion by 2026Q1, a contraction driven by persistent net losses that signal a weakening financial foundation and significant challenges in stabilizing the company's long-term capital structure.
The consistent decline in retained earnings, which shifted from a positive $205 million to a deficit of $1.6 billion over the observed period, suggests that the company is consuming its capital base to fund restructuring and operational shortfalls. This trajectory warrants caution, as the erosion of equity significantly limits the company's financial flexibility during a period of intense industry competition.
As reported in financial statements, XRAY's debt-to-equity ratio has surged from 0.70 in 2023Q4 to 1.77 in 2026Q1, indicating that the company's reliance on debt is increasing precisely as its equity cushion is being depleted by ongoing operational losses and impairment charges.
While the absolute debt level has remained relatively stable near $2.3 billion, the rising leverage ratio is a function of a shrinking denominator rather than aggressive borrowing. This dynamic suggests that the company's ability to service its obligations may become increasingly constrained if the current trend of negative net income persists.
Based on reported figures, XRAY's goodwill has declined from $2.4 billion in 2023Q4 to $1.1 billion in 2026Q1, reflecting significant write-downs that suggest previous acquisition strategies have failed to deliver the expected economic value to the core dental technology and equipment business.
The reduction in goodwill, coupled with a stagnant PPE base, indicates that the company is actively clearing impaired assets from its balance sheet. Investors should monitor whether further write-downs are necessary, as the current asset mix remains heavily weighted toward intangible value that may not be fully supported by current cash flow generation.
Data from recent balance sheets reveals that XRAY's cash position has fallen to $190 million in 2026Q1 from a peak of $398 million in 2025Q1, highlighting a tightening liquidity buffer that may leave the firm exposed to unexpected shocks in its working capital requirements.
The current ratio of 1.53 provides a superficial sense of security, but the rapid depletion of cash reserves suggests that the company is burning through its liquid assets to sustain operations. This trend indicates that the firm's ability to fund its ongoing restructuring without external financing may be reaching a critical inflection point.
Quick answers to the most common questions about buying XRAY stock.
As of 2025, DENTSPLY SIRONA Inc. (XRAY) had total assets of $5.43B including $2.02B in current assets.
DENTSPLY SIRONA Inc. (XRAY) carries total debt of $2.47B, offset by $326.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
DENTSPLY SIRONA Inc. (XRAY) has total shareholders' equity (book value) of $1.34B ($6.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.
DENTSPLY SIRONA Inc. (XRAY) reported a current ratio of 1.51x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.